Valeant `Happy' to Negotiate With Allergan: CEO

July 21 (Bloomberg) -- Mike Pearson, chief executive officer of Valeant Pharmaceuticals International Inc., talks about the company's hostile bid for Allergan Inc. He speaks with Stephanie Ruhle and Erik Schatzker on Bloomberg Television's "Market Makers." (Source: Bloomberg)

Twitter, Tesla Report: What'd You Miss? (Full Show 02/10)
13:36 - Full episode of "What'd You Miss?" Guests: Brad Hintz, adjunct professor of finance at NYU Stern School of Business and former Lehman chief financial officer, and Roger Farmer, economics professor at UCLA. (Source: Bloomberg)
  • Stock Exchange: Top Asia Equities Movers
  • Who's to Blame for Current Market Volatility?
  • EVE: Valkyrie: Oculus Rift's Flagship VR Game